Phase II Trial Of Depsipeptide In Patients With Cutaneous T-Cell Lymphoma And Relapsed Peripheral T-Cell Lymphoma.
Latest Information Update: 03 Oct 2021
At a glance
- Drugs Romidepsin (Primary)
- Indications Cutaneous T-cell lymphoma; Peripheral T-cell lymphoma
- Focus Registrational; Therapeutic Use
- 13 Apr 2017 Status changed from active, no longer recruiting to completed.
- 13 Apr 2017 Status changed from active, no longer recruiting to completed.
- 14 Jan 2016 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016, according to ClinicalTrials.gov record.